These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31564830)

  • 1. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.
    Yuan M; Meng XW; Ma J; Liu H; Song SY; Chen QC; Liu HY; Zhang J; Song N; Ji FH; Peng K
    Drug Des Devel Ther; 2019; 13():3137-3149. PubMed ID: 31564830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
    Zhang Y; Zhao Q; Li X; Ji F
    Mol Cell Biochem; 2021 Jul; 476(7):2803-2812. PubMed ID: 33725228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSP70 protects H9C2 cells from hypoxia and reoxygenation injury through STIM1/IP3R.
    Liu T; Juan Z; Xia B; Ren G; Xi Z; Hao J; Sun Z
    Cell Stress Chaperones; 2022 Sep; 27(5):535-544. PubMed ID: 35841499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine Attenuates Cellular Injury and Apoptosis in H9c2 Cardiomyocytes by Regulating p-38MAPK and Endoplasmic Reticulum Stress.
    Zhu Z; Ling X; Zhou H; Zhang C; Yan W
    Drug Des Devel Ther; 2020; 14():4231-4243. PubMed ID: 33116411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
    Chang JH; Jin MM; Liu JT
    Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine inhibits apoptosis of astrocytes induced by oxygen-glucose deprivation via targeting JAK/STAT3 signal pathway.
    Feng P; Zhang A; Su M; Cai H; Wang X; Zhang Y
    Brain Res; 2021 Jan; 1750():147141. PubMed ID: 33017590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway.
    Shi X; Liu Z; Li J
    Mol Med Rep; 2020 Oct; 22(4):3307-3315. PubMed ID: 32945482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrine alleviates AGEs- induced cardiac dysfunctions by attenuating calcium overload via reducing ryanodine receptor 2 activity.
    Wang J; Tang Z; Zhang Y; Qiu C; Zhu L; Zhao N; Liu Z
    Eur J Pharmacol; 2019 Jan; 842():118-124. PubMed ID: 30339815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine protects cardiac microvascular endothelial cells from the damage of ogd/r through regulation of the pparδ-mediated autophagy.
    Shao Q; Xia J; Wu P; Ying J
    Microcirculation; 2021 May; 28(4):e12675. PubMed ID: 33377581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine Protects Cardiomyocytes against Hypoxia/Reoxygenation Injury by Suppressing TLR4-MyD88-NF-
    Gao JM; Meng XW; Zhang J; Chen WR; Xia F; Peng K; Ji FH
    Biomed Res Int; 2017; 2017():1674613. PubMed ID: 29359143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alleviation effects of dexmedetomidine on myocardial ischemia/reperfusion injury through fatty acid metabolism pathway via Elovl6.
    Yuan H; Guo J; Wang C; Zhang C
    Int Immunopharmacol; 2024 Sep; 138():112588. PubMed ID: 38955031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
    Zhao Y; Kong GY; Pei WM; Zhou B; Zhang QQ; Pan BB
    Eur Cytokine Netw; 2019 Sep; 30(3):88-97. PubMed ID: 31957703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine at a dose of 1 µM attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress.
    Zhu Z; Ling X; Zhou H; Zhang C
    Exp Ther Med; 2021 Feb; 21(2):132. PubMed ID: 33376514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine post-treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF-1α signalling.
    Peng K; Chen WR; Xia F; Liu H; Meng XW; Zhang J; Liu HY; Xia ZY; Ji FH
    J Cell Mol Med; 2020 Jan; 24(1):850-861. PubMed ID: 31680420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of Stim1 reduced intracellular calcium concentration and attenuated hypoxia/reoxygenation induced apoptosis in H9C2 cells.
    He F; Wu Q; Xu B; Wang X; Wu J; Huang L; Cheng J
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29089467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference with GPR4 inactivates NLRP3 inflammasome signaling by inhibiting LPAR1 expression to ameliorate oxygen-glucose deprivation/reoxygenation-induced inflammation and apoptosis of cardiomyocytes.
    He H; Su H; Chen X; Chen X; Yang S
    Prostaglandins Other Lipid Mediat; 2024 Oct; 174():106863. PubMed ID: 38936540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.
    Yang FY; Zhang L; Zheng Y; Dong H
    Bioengineered; 2022 Jan; 13(1):1377-1387. PubMed ID: 34974801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine protects against oxygen-glucose deprivation/reoxygenation injury-induced apoptosis via the p38 MAPK/ERK signalling pathway.
    Wang K; Zhu Y
    J Int Med Res; 2018 Feb; 46(2):675-686. PubMed ID: 29210287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms.
    Cai S; Liu Y; Cheng Y; Yuan J; Fang J
    J Clin Lab Anal; 2022 Jul; 36(7):e24119. PubMed ID: 34882841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine protects hepatic cells against oxygen-glucose deprivation/reperfusion injury via lncRNA CCAT1.
    Zhou Z; Chen Q; Wan L; Zheng D; Li Z; Wu Z
    Cell Biol Int; 2018 Sep; 42(9):1250-1258. PubMed ID: 29851220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.